R

Remed Co Ltd
KOSDAQ:302550

Watchlist Manager
Remed Co Ltd
KOSDAQ:302550
Watchlist
Price: 3 185 KRW 2.58%
Market Cap: ₩100.3B

Remed Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Remed Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
R
Remed Co Ltd
KOSDAQ:302550
Research & Development
-₩3.5B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
J
Jeisys Medical Inc
KOSDAQ:287410
Research & Development
-₩3.4B
CAGR 3-Years
-54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Research & Development
-₩16.7B
CAGR 3-Years
-60%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
W
Won Tech Co Ltd
KOSDAQ:336570
Research & Development
-₩1.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Research & Development
-₩2.9B
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Seers Technology Co Ltd
KOSDAQ:458870
Research & Development
-₩4.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Remed Co Ltd
Glance View

Market Cap
100.3B KRW
Industry
Health Care

REMED Co., Ltd. is engaged in the manufacturing of other medical equipment. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2018-08-14. The firm is involved in the manufacturing and sale of transcranial magnetic stimulation (TMS) therapy machines, pain therapy machines, electrosurgical units as well as biosignal and monitoring machines. The pain therapy machines include electromagnetic stimulation machines, extracorporeal shockwave therapy machines and high intensity laser therapy machines, among others. The biosignal and monitoring machines include patient monitors, fetal monitors, electrocardiogram (ECG/EKG) machines, among others. The firm distributes its products within the domestic market and to overseas markets.

Intrinsic Value
1 647.39 KRW
Overvaluation 48%
Intrinsic Value
Price
R

See Also

What is Remed Co Ltd's Research & Development?
Research & Development
-3.5B KRW

Based on the financial report for Dec 31, 2024, Remed Co Ltd's Research & Development amounts to -3.5B KRW.

What is Remed Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-10%

Over the last year, the Research & Development growth was -18%. The average annual Research & Development growth rates for Remed Co Ltd have been -8% over the past three years , -10% over the past five years .

Back to Top